BIOVIE INC.
PublicBiotech · Carson City, NV
Financials
FY2013–FY2026 · from SEC filings · hover any figure for its sourceChart shows the most recent 8 fiscal years; 6 earlier years are in the table below.
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Pre-money — the valuation set before each round’s money came inDotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.
Cap table
Share counts as of Dec 31, 2024| Class | Outstanding | Votes / share | Share of total | Last price |
|---|---|---|---|---|
| Class A Common Stock | 18,451,584 | — | 100.0% | — |
Shares outstanding over timein today's share terms
Changes in named holdersshares in today's terms · % of all shares at the time
- Joanne Wendy Kim5K Sep 2022 → 8K Aug 2023
Principal holders% as the filing states it, Aug 16, 2023
- Stockholders Acuitas Group Holdings30,503,938 shares69.1%of company
- Joanne Wendy Kim80,397 shares4.8%of company
From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.
Fundraising history
SEC filings
View all 61 filings on EDGAR- Form 10-KAug 13, 20260001520138-26-000332EDGAR
- Form 10-QMay 11, 20260001520138-26-000154EDGAR
- Form 10-QFeb 6, 20260001520138-26-000052EDGAR
- Form 10-QNov 10, 20250001520138-25-000343EDGAR
- Form 10-KAug 15, 20250001520138-25-000268EDGAR
- Form 10-QMay 12, 20250001520138-25-000144EDGAR
- Form 10-QFeb 11, 20250001520138-25-000056EDGAR
- Form 1-ADec 31, 20240001520138-24-000502EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.